Dr. Raja Mudad
Internal Medicine - Oncology
1 doctor agrees

In brief: More

The median survival of non-small cell lung cancer in the us is 12-14 months.
That means, 50% of patients live more than that and 50% live less than that. Most patient live at least a year.

In brief: More

The median survival of non-small cell lung cancer in the us is 12-14 months.
That means, 50% of patients live more than that and 50% live less than that. Most patient live at least a year.
Thank
Dr. Frank Mayo
Internal Medicine - Pulmonary Critical Care

In brief: Poor

Description suggests stage 4 disease with metastatic disease in 2 additional organ systems.
Despite advances in therapy for lung cancer survival to 6 mo with this extent of disease is likely 25 to 30 %.

In brief: Poor

Description suggests stage 4 disease with metastatic disease in 2 additional organ systems.
Despite advances in therapy for lung cancer survival to 6 mo with this extent of disease is likely 25 to 30 %.
Thank
Get help from a real doctor now
Dr. Bennett Machanic
Board Certified, Neurology
51 years in practice
56M people helped
Continue
100,000 doctors available